EKF Diagnostics Holdings Plc - Asset Resilience Ratio

Latest as of December 2024: -1.58%

EKF Diagnostics Holdings Plc (EKF) has an Asset Resilience Ratio of -1.58% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

GBX-1.29 Million
≈ $-156.83 USD Cash + Short-term Investments

Total Assets

GBX81.75 Million
≈ $9.95K USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2009–2024)

This chart shows how EKF Diagnostics Holdings Plc's Asset Resilience Ratio has changed over time. Check EKF strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down EKF Diagnostics Holdings Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see EKF market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents GBX0.00 0%
Short-term Investments GBX-1.29 Million -1.58%
Total Liquid Assets GBX-1.29 Million -1.58%

Asset Resilience Insights

  • Limited Liquidity: EKF Diagnostics Holdings Plc maintains only -1.58% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

EKF Diagnostics Holdings Plc Industry Peers by Asset Resilience Ratio

Compare EKF Diagnostics Holdings Plc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Double Medical Technology Inc
SHE:002901
Medical Devices 12.59%
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
Medical Devices 49.23%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Vitrolife AB
ST:VITR
Medical Devices 7.27%
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
Imricor Medical Systems Inc
AU:IMR
Medical Devices 46.50%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%

Annual Asset Resilience Ratio for EKF Diagnostics Holdings Plc (2009–2024)

The table below shows the annual Asset Resilience Ratio data for EKF Diagnostics Holdings Plc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 -1.58% GBX-1.29 Million
≈ $-156.83
GBX81.75 Million
≈ $9.95K
-1.66pp
2011-12-31 0.09% GBX51.00K
≈ $6.21
GBX58.73 Million
≈ $7.15K
-0.19pp
2010-12-31 0.28% GBX100.00K
≈ $12.17
GBX35.98 Million
≈ $4.38K
-7.12pp
2009-12-31 7.39% GBX473.00K
≈ $57.55
GBX6.40 Million
≈ $778.33
--
pp = percentage points

About EKF Diagnostics Holdings Plc

LSE:EKF UK Medical Devices
Market Cap
$1.35 Million
GBX11.09 Billion GBX
Market Cap Rank
#30358 Global
#757 in UK
Share Price
GBX25.75
Change (1 day)
+0.39%
52-Week Range
GBX21.80 - GBX31.90
All Time High
GBX78.21
About

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more